[Pityriasis-lichenoides-et-varioliformis-acuta-like drug exanthema caused by astemizole].
We report on a 40-year-old male patient who developed an unusual generalized drug eruption taking the form of a histologically confirmed pityriasis lichenoides et varioliformis acuta (PLEVA) after oral intake of the H1-antagonist astemizole. On two occasions, independently repeated medication with astemizole exacerbated the typical rash again. Oral exposure and the specific lymphocyte transformation test confirmed the suspected causal connection between astemizole and PLEVA.
Stosiek
N
N
Universitäts Hautklinik Erlangen.
Peters
K P
KP
von den Driesch
P
P
D000284:Administration, Oral; D000328:Adult; D016589:Astemizole / Q000008:administration & dosage / Q000009:adverse effects*; D001706:Biopsy; D003875:Drug Eruptions / Q000175:diagnosis* / Q000473:pathology; D006801:Humans; D008297:Male; D017514:Pityriasis Lichenoides / Q000139:chemically induced* / Q000473:pathology; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012867:Skin / Q000473:pathology
D016589:Astemizole
Pityriasis-lichenoides-et-varioliformis-acutaähnliches Arzneiexanthem durch Astemizol.